Pablo Umaña, Ph.D. is Chief Scientific Officer and co-founder of GLYCART. He holds an M.Sc. in Chemical Engineering from Caltech, a Ph.D. in Chemical Engineering and Biology from Caltech, and was a postdoctoral research fellow in molecular medicine at the University of Manchester.

While working at the laboratory of Prof. James E. Bailey at the ETH Zurich, he created the base for the development and patenting of GLYCART’s core technology (GlycoMAb). Dr. Umaña is the principal inventor of numerous patents and patent applications covering GLYCART’s technologies and antibody products.